Non-hodgkin Lymphoma
📧 Sign up to get email alerts when something new happens for Non-hodgkin Lymphoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2011-09-28Clinical Trial Update: Study of the Safety and Tolerability of Oral Capsule Form of PCI-24781 in Advanced Cancer Patients [Phase 1]
This Phase 1 study evaluated the safety and tolerability of an oral capsule form of PCI-24781 in adults with advanced cancers, and the trial…
-
CLINICAL_TRIALS research · 2011-09-27Clinical Trial Update: Study of the Best Timing for Plerixafor in Autologous Hematopoietic Stem Cell Collection [NA]
This document reports a clinical trial update evaluating the best timing for administering plerixafor during autologous hematopoietic stem c…
-
CLINICAL_TRIALS trial_result · 2011-09-16Clinical Trial Update: Clofarabine and Rituximab in Treating Patients With Relapsed Non-Hodgkin Lymphoma [Phase 1, Phase 2]
Phase 1/2 trial evaluating clofarabine in combination with rituximab for relapsed non-Hodgkin lymphoma; study terminated with results posted…
-
CLINICAL_TRIALS trial_result · 2011-08-26Clinical Trial Update: Radiation Therapy and Cyclophosphamide Plus Peripheral Stem Cell Transplantation in Treating Patients With Recurrent or Refractory Hodgkin's Disease or Non-Hodgkin's Lymphoma [Phase 2]
This Phase 2 trial update reports completion of a study evaluating radiation therapy with cyclophosphamide followed by peripheral stem cell …
-
CLINICAL_TRIALS trial_result · 2011-08-04Clinical Trial Update: Trial of AVN-944 in Patients With Advanced Hematologic Malignancies [Phase 1]
A Phase 1 trial evaluating AVN-944 in patients with advanced hematologic malignancies has completed, spanning acute and chronic leukemia, mu…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2011-08-03Clinical Trial Update: Phase II Study of ONTAK in Previously Treated Patients With Low-grade Non-Hodgkin's Lymphoma (NHL) [Phase 2]
A Phase II study of denileukin diftitox (Ontak) in previously treated patients with low-grade non-Hodgkin's lymphoma has completed, with res…
-
CLINICAL_TRIALS trial_result · 2011-08-03Clinical Trial Update: Interleukin-12 Plus Rituximab in Treating Patients With Non-Hodgkin's Lymphoma [Phase 1]
Phase 1 study of Interleukin-12 plus Rituximab in patients with Non-Hodgkin lymphoma has completed.
-
CLINICAL_TRIALS trial_result · 2011-07-26Clinical Trial Update: Study of VELCADE and Rituximab in Patients With Relapsed or Refractory B-cell Non-Hodgkin's Lymphoma [Phase 3]
A Phase 3 trial evaluating Velcade (bortezomib) in combination with Rituximab for relapsed or refractory B-cell non-Hodgkin lymphoma has bee…
-
CLINICAL_TRIALS trial_result · 2011-07-13Clinical Trial Update: An Open-Label Study to Assess the Effect of CYP3A4 Induction on the Pharmacokinetics of VELCADE (Bortezomib) [Phase 1]
This completed Phase 1 open-label study assessed whether CYP3A4 induction alters the pharmacokinetics of bortezomib (Velcade) in patients wi…
-
CLINICAL_TRIALS trial_result · 2011-06-06Clinical Trial Update: Pilot Study of Bortezomib, Bendamustine and Rituximab on Non-Hodgkin's Lymphoma [Phase 2]
Phase 2 pilot trial evaluating a combination of bortezomib, bendamustine, and rituximab in non-Hodgkin lymphoma; results were posted in 2011…
-
CLINICAL_TRIALS trial_result · 2011-06-02Clinical Trial Update: Clinical and Pathologic Studies in Non-Hodgkin's Lymphoma Patients Receiving Antibody Treatment [NA]
This clinical trial update notes completion of studies in Non-Hodgkin lymphoma patients treated with an antibody therapy.
-
CLINICAL_TRIALS trial_result · 2011-05-23Clinical Trial Update: A Study to Evaluate the Effect of Weekly PROCRIT (Epoetin Alfa) or Placebo on Anemia and Quality of Life in Children With Cancer Undergoing Chemotherapy [Phase 3]
A Phase 3 study evaluating weekly epoetin alfa (PROCRIT) versus placebo for anemia and quality of life in children receiving chemotherapy fo…
-
CLINICAL_TRIALS trial_result · 2011-05-17Clinical Trial Update: FR901228 in Treating Patients With Myelodysplastic Syndrome, Acute Myeloid Leukemia, or Non-Hodgkin's Lymphoma [Phase 2]
Phase 2 clinical trial evaluating romidepsin (FR901228) in patients with myelodysplastic syndromes, acute myeloid leukemia, or non-Hodgkin l…
-
CLINICAL_TRIALS trial_result · 2011-05-03Clinical Trial Update: Ifosfamide/Carboplatin/Etoposide/Rituxan Followed by Zevalin in Relapsed/Refractory Intermediate Grade B-Cell Lymphoma [Phase 2]
A Phase 2 trial assessing a chemotherapy regimen (Ifosfamide, Carboplatin, Etoposide) with Rituximab followed by Zevalin for relapsed/refrac…
-
FDA approval · 2011-04-25FDA Approved: METHOTREXATE — Supplemental Application (Hikma Pharmaceuticals USA Inc.)
The FDA approved a supplemental application for METHOTREXATE from Hikma Pharmaceuticals USA Inc., granting a supplemental approval for the g…
-
CLINICAL_TRIALS trial_result · 2011-04-21Clinical Trial Update: AIDS and Cancer Specimen Bank (ACSB)
AIDS and Cancer Specimen Bank (ACSB) clinical trial update shows the study status is COMPLETED. The listed conditions include AIDS-related K…
-
CLINICAL_TRIALS trial_result · 2011-03-29Clinical Trial Update: VP and G-CSF With or Without Rituximab in Autologous Peripheral Stem Cell Transplant For NHL [NA]
This completed clinical trial evaluated VP and G-CSF with or without Rituximab as part of autologous peripheral stem cell transplantation fo…
-
CLINICAL_TRIALS trial_result · 2011-03-14Clinical Trial Update: DepoCyt for Active Lymphomatous or Leukemic Meningitis [Phase 2]
Phase 2 trial of DepoCyt (liposomal cytarabine) for active lymphomatous or leukemic meningitis was terminated; results were posted in 2011.
-
CLINICAL_TRIALS trial_result · 2011-03-08Clinical Trial Update: The Effectiveness of the Screening Inventory of Psychosocial Problems (SIPP) in Cancer Patients [NA]
The study evaluating the effectiveness of the Screening Inventory of Psychosocial Problems (SIPP) in cancer patients has completed. It was s…
-
CLINICAL_TRIALS trial_result · 2011-01-28Clinical Trial Update: Non-randomized Safety Study With Bortezomib/Rituximab in Relapsed/Refractory Indolent Lymphoma [Phase 2]
This document reports the completion of a Phase 2 non-randomized safety study evaluating the combination of Bortezomib and Rituximab in rela…
-
CLINICAL_TRIALS trial_result · 2011-01-17Clinical Trial Update: Oral Combination Chemotherapy in Treating Elderly Patients With Intermediate or High-Grade Non-Hodgkin's Lymphomas [Phase 2]
Phase 2 trial evaluating an oral combination chemotherapy for elderly patients with intermediate- or high-grade Non-Hodgkin lymphoma has bee…
-
CLINICAL_TRIALS research · 2011-01-12Clinical Trial Update: Study to Evaluate an Oxaliplatin-based Chemotherapy in Patients With Resistant or Relapsing Non-Hodgkin Lymphoma. [Phase 2]
This document announces a Phase 2 clinical trial evaluating an oxaliplatin-based chemotherapy regimen in patients with resistant or relapsed…
-
FDA approval · 2011-01-07FDA Approved: FOLOTYN — Supplemental Application (Acrotech Biopharma Inc)
FDA approved a supplemental application for FOLOTYN (pralatrexate) from Acrotech Biopharma Inc.
-
CLINICAL_TRIALS trial_result · 2011-01-07Clinical Trial Update: Mechanism of Action of Galiximab in Subjects With Previously Untreated Follicular Non-Hodgkin's Lymphoma [Phase 1]
Phase 1 study evaluating the mechanism of action of galiximab in previously untreated follicular non-Hodgkin's lymphoma; the trial status is…
-
CLINICAL_TRIALS trial_result · 2010-12-30Clinical Trial Update: Rituximab and Chemotherapy Followed by Ibritumomab Tiuxetan as Treatment for Low Grade Follicular Non-Hodgkin's Lymphoma [Phase 2]
Phase 2 trial evaluating Rituxan (rituximab) and chemotherapy followed by Zevalin (ibritumomab tiuxetan) for low-grade follicular non-Hodgki…